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a b s t r a c t 
Objectives: Men who have sex with men (MSM) are at risk of human papillomavirus (HPV)-related can- 
cers, while published data are scarce. This study determined HPV prevalence and risk factors in MSM in 
Vietnam to inform HPV prevention strategies in this key population. 
Methods: A cross-sectional study of 799 MSM aged 16-50 years was conducted in Vietnam in 2017-2018. 
Information was collected on risk behaviours, and knowledge of HPV and anal cancer; rectal swabs were 
taken to detect anal HPV infection. An in-house polymerase chain reaction and Genoflow HPV array test 
kit were used for HPV detection and genotyping. 
Results: The median age of the study participants was 25 years (range 18-52). Overall prevalence of any 
HPV and HPV16/18 infection was 32.3% and 11.0%, respectively. A higher prevalence of high-risk HPV 
infection to all 14 types tested was found in Ho Chi Minh City (30.9%) than in Hanoi (18.4%). High-risk 
HPV infection was associated with inconsistent condom use and history of engaging in sex under the 
influence of drugs (adjusted odds ratio (aOR), 2.27; 95% CI, 1.48-10.67), as well as having multiple sexual 
partners (aOR, 1.01; 95% CI, 1.00–1.02). 
Conclusions: High-risk anal HPV infections in Vietnamese MSM were significantly associated with risky 
sexual behaviours. A targeted HPV vaccination strategy would have substantial benefit for MSM in Viet- 
nam. 
© 2021 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious 
Diseases. 
This is an open access article under the CC BY-NC-ND license 
( http://creativecommons.org/licenses/by-nc-nd/4.0/ ) 
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Human papillomavirus (HPV) infection is the most common 
exually transmitted infection globally, affecting both men and 
omen ( Crosbie et al., 2013 ). Although the majority of HPV infec- 
ions are asymptomatic and transient ( Dunne et al., 2006 ), persis- 
ent HPV infections can lead to a range of diseases from benign 
nogenital warts (90% caused by HPV6/11) to life-threatening dis- 
ases such as anogenital and some oropharyngeal cancers ( > 70% 
aused by HPV16/18) ( Daling et al., 2004 ; Frisch et al., 1999 ;
arland et al., 2009 ; Hoots et al., 2009 ; Parkin and Bray, 2006 ;
accarella et al., 2010 ). 
As with cervical cancer, most anal cancers are squamous cell 
arcinomas, and 90% of them are caused by HPV infection, par- 
icularly with HPV16 ( Daling et al., 2004 ; Frisch et al., 1999 ;
illman et al., 2014 ; Parkin and Bray, 2006 ). Anal cancer in- 
idence and mortality have risen sharply over the last decade 
 Deshmukh et al., 2020 ; Nelson et al., 2013 ). Most cases have
een recorded in high-income countries, while data are scarce 
n low-income and middle-income countries ( Islami et al., 2016 ). 
he age standardized rate of anal cancer in Vietnam is 0.3 
er 10 0,0 0 0 males per year ( http://hpvcentre.net/statistics/reports. 
NM.pdf ). Compared with heterosexual men and women, MSM 
re at increased risk of HPV infection and HPV-associated dis- 
ases, such as anogenital warts and anal cancer, due to risky 
exual behaviours such as practicing anal intercourse and having 
ultiple sexual partners ( Daling et al., 2004 ; Daling et al., 1982 ;
rulich et al., 2012 ; Machalek et al., 2012 ; Nyitray et al., 2016 ;
alefsky et al., 2011 ). Furthermore, they are often not targeted 
y HPV vaccination and, unlike heterosexual men, MSM are un- 
ikely to benefit from herd effects from girls-only HPV vaccination 
 Ali et al., 2013 ). 
There are currently three licensed prophylactic HPV vac- 
ines (Cervarix®, bivalent - 2vHPV; Gardasil®, quadrivalent - 
vHPV; and Gardasil®9, nonavalent - 9vHPV) that protect against 
PV16/18 infections. Both the 4vHPV and 9vHPV protect against 
0% of anogenital warts cases. The 9vHPV protects against an ad- 
itional five high-risk HPV types: HPV31/33/45/52 and 58. These 
hree vaccines will likely protect against anal cancers caused by 
hese HPV types, although only 4vHPV and 9vHPV are currently 
icensed for the prevention of anal cancer. The 4vHPV has demon- 
trated 50.3% and 77.5% efficacy against anal intraepithelial neo- 
lasia, the precursor of anal cancer, in young men who were pre- 
iously infected with HPV and those who were HPV-naïve, respec- 
ively ( Palefsky et al., 2011 ). 
In Vietnam, little is known about the epidemiology and preva- 
ence of HPV among MSM. There are currently no HPV preven- 
ion programs for MSM and men who have sex with women be- 
ause the HPV vaccine is yet to be recommended for males in Viet- 
am. Access to HPV screening and testing in the MSM population 
emains limited, unless they present with symptoms of sexually 
ransmitted infections. This cross-sectional study was conducted to 
etermine the demographic, behavioural patterns and HPV preva- ∗ Corresponding author. 
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137 ence among MSM in two of the largest cities in Vietnam – Hanoi 
nd Ho Chi Minh City (HCMC) – to inform HPV prevention strate- 
ies for MSM in Vietnam. 
ethods 
thics approval 
The study was reviewed and approved by the ethics review 
oards of the National Institute of Hygiene and Epidemiology 
NIHE), Vietnam (IRB-VN01057-13/2017) and London School of Hy- 
iene & Tropical Medicine, UK (reference number: 14207). 
tudy design and population 
This community-based, cross-sectional study was conducted in 
anoi and HCMC between December 2017 and February 2018. Men 
ged 16-50 years who reported a history of having anal sex with 
en in the last month prior to their first study visit were re- 
ruited. The respondent-driven sampling (RDS) method was used 
o recruit this “hard-to-reach” study population of participants. 
he RDS sampling process began with the recruitment of “seed”
embers among the MSM population. First, seeds were selected 
hrough discussions with peer educators and staff of outreach pro- 
rammes. Study-participated seeds were then asked to randomly 
ecruit a maximum of three other members of their population 
rom their network to the study by distributing invitation coupons 
o introduce subsequent participants. Thereafter, each MSM re- 
ruited and enrolled in the study received up to three recruitment 
oupons used to recruit their peers into the study. Each coupon 
as uniquely coded to link recruiters with those recruited. If the 
ecruitment chains “dried up”, new seeds were selected based on 
he inclusion criteria. In Hanoi, 399 MSM were recruited through 
hree seeds and five waves of the RDS recruitment process, while 
n HCMC, 400 MSM were recruited through 15 seeds and six waves 
 Appendix 1 ). All participants provided written informed consent 
o answer the questionnaire and to have anal swabs taken. Individ- 
als were allowed to participate in this study only once. No partic- 
pants withdrew from the study after providing consent. 
ata collection 
Participants completed a face-to-face interview with study 
urse/staff on questionnaires related to the demographics, sexual 
ehaviour, knowledge of HPV and associated diseases, as well as 
heir willingness to be vaccinated. An anal swab specimen was 
ollected from each participant by a trained medical professional. 
he swab was placed in a tube containing 1 ml of specimen trans- 
ort media (Qiagen, Germany). On the same day, the samples were 
ent for processing at the laboratories in the National Institute of 
ygiene and Epidemiology (NIHE) in Hanoi or Pasteur Institute in 
CMC. In the laboratory, the swabs were vortexed in the transport 
edia, aliquoted and stored at -30 °C until further analysis. 
PV detection and genotyping test 
HPV detection and genotyping were performed using a two- 
tep method. First, nucleic acid extraction was performed using 
ador pathogen 96 Qiacube HT kit (Qiagen, Hilden, Germany) on 
he automated platform, followed by amplification with PGMY9/11 
y polymerase chain reaction (PCR) to detect HPV-DNA; HLA was 
sed as the internal control ( Human papillomavirus laboratory 
anual, 2010 ). HPV-DNA-positive samples by PCR were subjected 
o genotyping by Genoflow HPV array test kit (Diagcor, Hongkong), 
hich detected 33 HPV types (14 high-risk types, 3 probable high- 
isk types and 16 low-risk types): (i) high-risk and probable high- 
isk types: 16, 18, 31, 33, 35, 39, 45, 51, 52, 53, 56, 58, 59, 66, 68,

















































































































3, 82; and (ii) low-risk types: 6, 11, 40, 42, 43, 44, 54, 55, 57, 61,
0, 71, 72, 81, 26/84 ( Clifford et al., 2005 ; Walboomers et al., 1999 ).
he kit was authorised for in-vitro diagnostic usage and qualified 
y the World Health Organization (WHO) HPV LabNet for high-risk 
PV detection and genotyping. 
The human leukocyte antigen (HLA) and beta-globulin genes 
ere used as internal controls for the PGMY9/11 PCR assay and 
enoflow kit, respectively. Samples negative for HLA gene were 
onsidered invalid. For each laboratory, external quality assurance 
as performed on a panel of 40 previously tested samples prior to 
creening test by HPV LabNet at the Western Pacific WHO refer- 
nce laboratory, Melbourne, Australia. There was ∼90% agreement 
etween labs for all samples, and some discordant/missed results 
ere found for certain tested hrHPV genotypes: 4/20 for HPV16, 
/12 for HPV18, 1/4 for HPV31, 2/12 for HPV39, 2/7 for HPV45, 3/9 
or HPV56, 2/17 for HPV58, and 3/16 for HPV 66. 
tatistical analyses 
The overall and type-specific prevalence of anal HPV infection 
rom Hanoi and HCMC were calculated. In these analyses, HPV 
enotypes were classified based on IARCs classification. The RDS- 
djustment methods ( Gile and Handcock, 2010 ) were used to esti- 
ate 95% confidence intervals (CI) of HPV infection ( Clopper and 
earson, 1934 ). Between-city differences were evaluated using Chi- 
quare test or Fisher’s exact test for categorical variables and Stu- 
ent’s t -test or Mann-Whitney U test for continuous variables, 
here appropriate. Logistic regression was performed to determine 
articipants’ sociodemographics and sexual behaviours that were 
ssociated with high-risk anal HPV infection at the time of screen- 
ng. Variables with a significance level of p < 0.10 in the bivariate 
nalyses were included in the multivariable model. Nested models 
ere compared using the likelihood ratio test. Data analyses were 
erformed in R version 3.6.3 ( Team, 2018 ). 
esults 
articipant characteristics 
From December 2017 to February 2018, a total of 799 MSM with 
he median age of 25 years (range: 18-52) from Hanoi and HCMC 
ompleted the questionnaires. Participants’ sociodemographic, be- 
avioural, and clinical characteristics are presented in Table 1 . 
verall, the age of sexual debut, duration of sexual activity, and 
umber of sex partners in the last 12 months were similar for 
SM between both cities ( Table 1 ). Conversely, a higher propor- 
ion of MSM from Hanoi (58.9%) attained at least college educa- 
ion compared with MSM from HCMC (26.0%), while more risky 
ehaviours such as drug use, sex under drug influence (chemsex), 
roup sex, and inconsistent condom use were more generally ob- 
erved for MSM from HCMC than from Hanoi. Generally, the pro- 
ortions of MSM had good knowledge of HPV, preventative mea- 
ures and anal cancer in Hanoi were higher than in HCMC (at 
.0%, 25.3% and 21.8% in Hanoi compared with 0%, 0.8% and 1.3% 
n HCMC, respectively). All MSM participating in this study did 
ot get vaccinated for reasons such as: don’t know HPV vaccine 
86.98%), don’t know where to get vaccine (14.5%) and other rea- 
ons (4.0%) ( Table 1 ). 
PV prevalence 
Of the 799 MSM who were screened, HPV DNA was detected 
n 238 (29.8%). The RDS-adjusted prevalence of any HPV, any high- 
isk HPV and HPV-16/18 infections among all subjects were 32.3% 
95% CI: 28.4–36.1%), 24.5% (95% CI: 21.1–27.9%) and 11.0% (95% 138 I: 8.5–13.4%), respectively. Prevalence of high-risk HPV was al- 
ost two-fold higher in HCMC (RDS-adjusted prevalence, 30.9; 
5% CI: 25.6–36.2%) than in Hanoi (RDS-adjusted prevalence, 18.4; 
5% CI: 15.2–21.5%). The most common HPV types among MSM 
n HCMC and Hanoi were HPV52 and HPV39, respectively, fol- 
owed by HPV66/68, HPV18 and HPV16 in both cities. Figure 1 de- 
icts the prevalence of the individual high-risk and low-risk HPV 
enotypes in MSM in Hanoi and HCMC, as well as the preva- 
ence of vaccine-preventable HPV types. Overall, the prevalence of 
accine-preventable HPV infection was 10.5% (95% CI: 5.8–15.2%) 
or the 2vHPV genotypes, 17.0% (95% CI: 11.5–22.5%) for the 4vHPV 
nd 20.9% (95% CI: 14.9–26.9%) for the 9vHPV. Almost a quarter 
23.0%) of the MSM aged < 25 years were infected with a vaccine- 
reventable genotype ( Figure 2 ). 
isk factors 
The unadjusted and adjusted association between high-risk anal 
PV infection and demographic and behavioural characteristics of 
he participants are summarised in Table 2 . In Hanoi, MSM who 
eported inconsistent condom use with a regular partner and sex 
orkers were associated with a two-fold (aOR, 2.03; 95% CI, 1.14–
.60) and four-fold (aOR, 4.22; 95% CI, 0.46–38.76) higher preva- 
ence of high-risk HPV infection, respectively. In HCMC, higher 
revalence’s of high-risk HPV infection were found in MSM who, 
n the last year, had engaged in chemsex (aOR, 2.27; 95% CI, 1.48–
0.67) or had multiple sex partners (aOR, 1.01; 95% CI, 1.00–1.02, 
or every additional partner). Interestingly, older MSM in Hanoi, 
ut not HCMC, were associated with a lower prevalence of high- 
isk HPV infection (aOR, 0.88; 95% CI, 0.77–1.03). Prevalence and 
isk factors for high-risk anal HPV infection among MSM differed 
cross the two cities ( Figure 2 ). Unlike in HCMC, infection with a 
igh-risk HPV genotype among MSM in Hanoi appeared to attenu- 
te with the number of years of being sexually active ( Figure 2 ). 
iscussion 
In this largest community-based HPV prevalence survey of MSM 
n both northern and southern Vietnam, it was found that one 
n three MSM had detectable anal HPV, and among them, one in 
our harboured at least one high-risk HPV genotype. In the cur- 
ent cohort, the high-risk HPV genotypes were significantly asso- 
iated with risky sexual behaviours such as inconsistent condom 
se, having multiple sexual partners and chemsex. 
The prevalence of high-risk anal HPV infection observed in this 
urvey of MSM was comparable with the prevalence rates previ- 
usly reported in Vietnam ( Le et al., 2019 ; Vu et al., 2013 ), al-
hough it did find higher high-risk anal HPV infections in HCMC 
han in Hanoi. Higher HPV prevalence was also observed in a pre- 
ious study of male sex workers where the prevalence was highest 
n Ho Chi Minh City (59%), followed by Hanoi (19%) and Nha Trang 
6%) ( Vu et al., 2013 ). Compared to the other countries in Asia, 
uch as Thailand (30) and China (28), lower HPV prevalence was 
bserved. This observation could be attributed to the study design 
nd study population, as well as small sample sizes that may over- 
stimate or underestimate the HPV prevalence in the community. 
n other studies, higher prevalence rates were often found in stud- 
es performed in sexual health clinics ( Chow et al., 2019 ; Miloševi ́c
t al., 2010 ; ; Supindham et al., 2015 ) since selection criteria in
hese clinic-based recruitments are usually biased toward higher- 
isk men. 
Persistent infection with high-risk anal HPV genotypes is a 
eal risk for anal cancer ( Hoots et al., 2009 ; Lin et al., 2018 ;
achalek et al., 2012 ). Compared to heterosexual men and women, 
SM are disproportionately more likely to have an anal HPV in- 
ection, which is related a precursors to anal cancer. Previous stud- 
L.A. Tuan, K. Prem, Q.D. Pham et al. International Journal of Infectious Diseases 112 (2021) 136–143 
Table 1 
Sociodemographic, behavioural characteristics, and HPV prevalence of participants (n = 799). 
Characteristics Hanoi (n = 399) HCMC (n = 400) Total (n = 799) 
Demographics 
Age (years) 
mean (SD) 25.8 (5.6) 29.4 (9) 27.6 (7.7) 
median (range) 24 (19-48) 26 (18-52) 25 (18-52) 
Attained college education and above, n (%) 235 (58.9) 104 (26) 339 (42.4) 
Marital status, n (%) 
never married 355 (89) 365 (91.2) 720 (90.1) 
married 7 (1.8) 4 (1) 11 (1.4) 
ever married (separated, divorced, widowed) 37 (9.2) 31 (7.8) 68 (8.5) 
Living arrangements 
alone 133 (33.3) 108 (27) 241 (30.2) 
with female partner 9 (2.3) 4 (1) 13 (1.6) 
with male partner 20 (5.0) 50 (12.5) 70 (8.8) 
with friends 168 (42.1) 37 (9.2) 205 (25.7) 
others 69 (17.3) 201 (50.2) 270 (33.8) 
Behaviours 
Ever smoked 96 (24.1) 150 (37.5) 246 (30.8) 
Ever consumed alcohol 285 (71.5) 273 (68.2) 558 (69.8) 
Ever consumed drugs 20 (5) 48 (12) 68 (8.5) 
Ever engaged in chemsex § 7 (1.8) 16 (4) 23 (2.9) 
Ever had in-group sex 29 (7.3) 55 (13.8) 84 (10.5) 
Inconsistent condom use with regular sex partner 214 (53.6) 242 (60.5) 456 (57.1) 
Inconsistent condom use with casual sex partner 2 (0.5) 77 (19.2) 79 (9.9) 
Inconsistent condom use with sex worker 6 (1.5) 22 (5.5) 28 (3.5) 
Ever had sex with both male and female partners 94 (23.6) 79 (19.8) 173 (21.7) 
Age of sex debut, in years, median (range) 18 (12-34) 18 (11-47) 18 (11-47) 
Duration of sexual activity, in years, median (range) 7 (2-28) 8.2 (2-35) 8 (2-35) 
Number of sex partners in the last 12 months, median (range) 2 (1-12) 2 (1-240) 2 (1-240) 
HPV prevalence 
Any HPV infection 106 (26.6) 132 (33) 238 (29.8) 
Any high-risk HPV infection † 76 (19) 116 (29) 192 (24) 
HPV 16/18 infection 36 (9) 49 (12.2) 85 (10.6) 
HPV vaccine 
Got HPV vaccine 0 (0) 0 (0) 0 (0) 
Reasons not to get vaccinated 
don’t know 305 (76.44) 390 (97.50) 695 (86.98) 
unnecessary 10 (2.51) 5 (1.25) 15 (1.88) 
worry about side effects 3 (0.75) 0 (0) 3 (0.38) 
expensive vaccine price 7 (1.75) 2 (0.50) 9 (1.13) 
don’t know where to get vaccine 115 (28.82) 1 (0.25) 116 (14.52) 
inconvenient location 5 (1.25) 0 (0) 5 (0.63) 
fear of being stigmatized 12 (3.01) 0 (0) 12 (1.50) 
don’t provide to male 6 (1.50) 3 (0.75) 9 (1.13) 
others 4 (1.00) 2 (0.50) 6 (0.75) 
HCMC, Ho Chi Minh City; SD, standard deviation 
† High-risk HPV types: 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66/68 








































es have found that high-risk sexual behaviours such as engaging 
n sex work, receptive anal intercourse, inconsistent condom use, 
nd high number of sexual partners are the strongest risk fac- 
ors for anal HPV infection ( Colon-Lopez et al., 2014 ; Dunne E. F.
t al., 2006 ; Muller et al., 2016 ; Nyitray et al., 2011 ; Tian et al.,
017 ; Zou et al., 2014 ). Similarly, the current study found that in-
onsistent condom use, having multiple sexual partners and chem- 
ex significantly increased the risk of high-risk HPV infections, al- 
hough this differed between HCMC and Hanoi, which might ex- 
lain the higher prevalence of any and high-risk HPV infections 
mong MSM in HCMC than in Hanoi. 
The two most prevalent high-risk HPV in each city were HPV52 
r HPV39 for HCMC and Hanoi, respectively, and HPV66/68. These 
PV types are not included in the 2vHPV or 4vHPV, and only 
PV52 is in the 9vHPV. Despite these, the proportion of anal can- 
ers attributed to these HPV types in Vietnam is unclear, and more 
tudies are needed to address this research gap to inform HPV pre- 
ention strategies. An interesting observation observed in Hanoi 
ut not HCMC is that the high-risk HPV genotype appears to atten- 
ate with the number of years of being sexually active, suggesting 
he possibility of natural immunity or latent infection. 139 Based on studies conducted in 2015, there are more than 
2,0 0 0 and 30,0 0 0 MSM in HCMC and in Hanoi, respectively 
 Safarnejad et al., 2017 ; Son et al., 2019 ). This large population of
SM in two of the largest cities in Vietnam are at risk of anal 
ancers as well as other HPV-associated diseases such as oropha- 
yngeal cancers and anogenital warts. HPV vaccination is the best 
ay to prevent HPV infections and HPV-associated diseases. The 
ntroduction of girls-only HPV vaccination would confer protec- 
ion for heterosexual men only if the coverage were high. How- 
ver, MSM are unlikely to benefit from herd effects of a girls-only 
accination programme. Evidence emerging from epidemiological 
nd modelling studies has led to the introduction of targeted MSM 
PV vaccination programmes in the United Kingdom and Australia 
 Datta et al., 2019 ; Zhang et al., 2017 ). Therefore, a targeted HPV
accination strategy for MSM in Vietnam could have substantial 
enefits. Future work investigating the willingness to receive HPV 
accination is crucial to the feasibility of HPV vaccination strategies 
or MSM in Vietnam. 
This study had some limitations, including that the participant 
dentification was based on RDS recruitment and may not have 
epresented individuals outside the participants’ networks. The 
L.A. Tuan, K. Prem, Q.D. Pham et al. International Journal of Infectious Diseases 112 (2021) 136–143 
Figure 1. Prevalence of high-risk and low-risk HPV types among MSM in Hanoi and HCMC after adjusting for respondent-driven sampling, 2017–2018 . 
Respondent-driven sampling method was used to estimate 95% CI of HPV infection for north Vietnam, Hanoi (in red) and south Vietnam, HCMC (in blue). The high-risk HPV 





































tudy focused on the age range 16-50 years, which is considered 
o be the sexually active period of MSM in Vietnam, thus might 
ave affected the generalizability of the results for the MSM popu- 
ation. In addition, it was unable to capture information on persis- 
ent HPV infection, which is an appropriate surrogate for anogen- 
tal precancers or cancers ( Daling et al., 2004 ; Frisch et al., 1999 ;
arkin and Bray, 2006 ). Other limitations included the study find- 
ngs on sexual activity – in last sex act, the past month, the past 
2 months – that were subject to recall bias. In addition, human 
mmunodeficiency virus (HIV) infection status of the study partic- 
pants, a major risk factor for HPV infection, was not collected, 
o there was no correlation with HPV prevalence ( Clifford et al., 
0 06 ; Orlando et al., 20 08 ; Palefsky and Holly, 2003 ). The national
IV surveillance, however, reported HIV prevalence of 10.9% among 
SM in Hanoi (Hanoi Medical University-National HIV/AIDS con- 
erence, 2018) and 13.6% among MSM in HCMC ( Nguyen et al., 
021 ). Nevertheless, this study did identify risk factors associated 
ith anal HPV infection among MSM in Hanoi and HCMC. 
In conclusion, this study identified several sociodemographic 
nd behavioural factors associated with the prevalence of inci- 
ent anal HPV infection, as well as the HPV genotypes circulat- 
ng among MSM in the two largest cities of Vietnam. The find- b
140 ngs have significant implications for the prevention of anal cancer 
mong MSM in Vietnam and Asia in general. The study highlights 
he need for better education on safe sex practices and HPV dis- 
ase awareness in men. The study also suggests that MSM should 
e considered for future HPV vaccination programs; it is already 
vailable for MSM in the UK, Canada and Australia. 
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L.A. Tuan, K. Prem, Q.D. Pham et al. International Journal of Infectious Diseases 112 (2021) 136–143 
Figure 2. Correlates of high-risk anal HPV infection among MSM in Hanoi and HCMC, 2017–2018 . 
Respondent-driven sampling method was used to estimate prevalence and their 95% CI of HPV infection for north Vietnam, Hanoi (in black) and south Vietnam, HCMC (in 
grey) and how it correlates to age, number of years since sexual debut, and number of sex partners in the past 12 months. The numbers of respondent in each bin are 
presented in parentheses. The high-risk HPV types included 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66/68. 
Table 2 
Correlations of factors associated with high-risk HPV infection. 
Hanoi (n = 399) HCMC § (n = 400) 
Any high-risk HPV † Bivariate analysis Multivariate analysis Any high-risk HPV † Bivariate analysis Multivariate analysis 
Variables N n % P OR (95% CI) ∗ OR (95% CI) ∗ N n % P OR (95% CI) ∗ OR (95% CI) ∗
Age, in years 0.91 (0.85-0.96) 0.88 (0.77-1.03) 0.97 (0.95-1.00) 0.94 (0.87-1.02) 
Attained college education 
and above 
235 44 18.7 1 0.95 (0.57-1.58) 0.90 (0.51-1.58) 104 40 38.5 0.02 1.81 (1.12-2.92) 1.87 (1.06-3.30) 
Marital status 
never married 355 73 20.6 0.04 1 365 110 30.1 0.06 1 
married 7 1 14.3 0.64 (0.08-5.45) 4 2 50 2.32 (0.32-16.75) 
ever married (i.e. 
separated, divorced, 
widowed) 
37 2 5.4 0.22 (0.05-0.95) 31 4 12.9 0.34 (0.11-1.01) 
Living arrangements 
alone 133 20 15 0.66 1 108 34 31.5 0.72 1 
with female partner 9 2 22.2 1.61 (0.31-8.40) 4 2 50 2.18 (0.28-16.34) 
with male partner 20 3 15 1 (0.27-3.73) 50 13 26 0.76 (0.36-1.62) 
with friends 168 36 21.4 1.54 (0.84-2.82) 37 12 32.4 1.04 (0.47-2.33) 
others (parents, siblings) 69 15 21.7 1.57 (0.74-3.31) 201 55 27.4 0.82 (0.49-1.37) 
Ever smoked 96 17 17.7 0.67 0.89 (0.49-1.62) 1.12 (0.54-2.32) 150 31 20.7 0.01 0.51 (0.31-0.82) 0.58 (0.31-1.08) 
Ever consumed alcohol 285 59 20.7 0.21 1.49 (0.82-2.69) 1.72 (0.90-3.28) 273 73 26.7 0.18 0.71 (0.45-1.13) 0.72 (0.42-1.21) 
Ever consumed drugs 20 1 5 0.14 0.21 (0.03-1.63) 48 16 33.3 0.59 1.26 (0.66-2.40) 
Ever engaged in chemsex 7 0 0 0.35 16 8 50 0.11 2.56 (0.93-7.02) 2.27 (1.48-10.67) 
Ever had in-group sex 29 5 17.2 0.87 0.88 (0.32-2.38) 55 20 36.4 0.26 1.48 (0.81-2.70) 
Inconsistent condom use 
with regular sex partner 
214 50 23.4 0.02 1.86 (1.10-3.15) 2.03 (1.14-3.60) 242 66 27.3 0.41 0.81 (0.52-1.26) 0.85 (0.50-1.47) 
Inconsistent condom use 
with casual sex partner 
2 0 0 1 77 19 24.7 0.43 0.76 (0.43-1.35) 
Inconsistent condom use 
with sex worker 
6 3 50 0.11 4.38 (0.85-22.37) 4.22 (0.46-38.76) 22 5 22.7 0.67 0.71 (0.25-1.97) 0.73 (0.15-3.61) 
Ever had sex with both 
male and female partners 
94 19 20.2 1 1.10 (0.62-1.97) 79 21 26.6 0.7 0.86 (0.49-1.50) 
Duration of sexual activity, 
in years, median (range) 
0.90 (0.84-0.96) 0.98 (0.96-1.01) 
Number of sex partners in 
the last 12 months, 
median (range) 
1.01 (0.85-1.21) 1.08 (0.88-1.32) 1.01 (1.00-1.02) 1.01 (1-1.02) 
OR, odds ratio, and its 95% confidence interval (CI) are presented in the brackets 
† High-risk HPV types: 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66/68 
§ HCMC: Ho Chi Minh City 
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